Page
%P
2 Result(s)
within
Anna Marie Chang
Cancer Research
-
Article
Open AccessAuthor Correction: IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
-
Article
Open AccessIL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial
Inflammation mediated by interleukin-6 (IL-6) is strongly associated with cardiovascular risk. Here we evaluated clazakizumab, a monoclonal antibody targeting the IL-6 ligand, in a phase 2b dose-finding study....
